GOLDENWELL BIOTECH, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

GOLDENWELL BIOTECH, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $2.3 thousand for the year ending 2023.

  • GOLDENWELL BIOTECH, INC. showed a decrease of -95.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2022 to 2023.
  • This data is from GOLDENWELL BIOTECH, INC.'s annual report (Form 10-K), filed with the SEC on April 12, 2024.
  • XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2023: $2.3 thousand | Fiscal year 2022: $47.8 thousand | Fiscal year 2021: $16.0 thousand | Fiscal year 2020: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: